1
|
Ishiguro H, Kimura M and Takeyama H: Role
of microRNAs in gastric cancer. World J Gastroenterol.
20:5694–5699. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kuo CY, Chao Y and Li CP: Update on
treatment of gastric cancer. J Chin Med Assoc. 77:345–353. 2014.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Xia J, Guo X, Yan J and Deng K: The role
of miR-148a in gastric cancer. J Cancer Res Clin Oncol.
140:1451–1460. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen L, Xiao H, Wang ZH, Huang Y, Liu ZP,
Ren H and Song H: miR-29a suppresses growth and invasion of gastric
cancer cells in vitro by targeting VEGF-A. BMB Rep. 47:39–44. 2014.
View Article : Google Scholar :
|
8
|
Feng R, Chen X, Yu Y, Su L, Yu B, Li J,
Cai Q, Yan M, Liu B and Zhu Z: miR-126 functions as a tumour
suppressor in human gastric cancer. Cancer Lett. 298:50–63. 2010.
View Article : Google Scholar : PubMed/NCBI
|
9
|
He XP, Shao Y, Li XL, Xu W, Chen GS, Sun
HH, Xu HC, Xu X, Tang D, Zheng XF, et al: Downregulation of miR-145
in gastric cancer correlates with cyclooxygenase-2 overexpression
and tumor growth. FEBS J. 279:4201–4212. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gao P, Xing AY, Zhou GY, Zhang TG, Zhang
JP, Gao C, Li H and Shi DB: The molecular mechanism of microRNA-145
to suppress invasion-metastasis cascade in gastric cancer.
Oncogene. 32:491–501. 2013. View Article : Google Scholar
|
11
|
Kim JG, Kim TO, Bae JH, Shim JW, Kang MJ,
Yang K, Ting AH and Yi JM: Epigenetically regulated MIR941 and
MIR1247 target gastric cancer cell growth and migration.
Epigenetics. 9:1018–1030. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh
SM, Song KS, Kim JC and Kim YS: Epigenetic regulation of
microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.
Epigenetics. 6:740–751. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
-145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S,
Guo X, Wang B, Gang Y, Zhang Y, et al: MiR-218 inhibits invasion
and metastasis of gastric cancer by targeting the Robo1 receptor.
PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B,
Gu J, Chen HY and Sun XF: Clinicopathological significance of
microRNA-31, -143 and -145 expression in colorectal cancer. Dis
Markers. 26:27–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ni Y, Meng L, Wang L, Dong W, Shen H, Wang
G, Liu Q and Du J: MicroRNA-143 functions as a tumor suppressor in
human esophageal squamous cell carcinoma. Gene. 517:197–204. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang Y, Hu C, Cheng J, Chen B, Ke Q, Lv Z,
Wu J and Zhou Y: MicroRNA-145 suppresses hepatocellular carcinoma
by targeting IRS1 and its downstream Akt signaling. Biochem Biophys
Res Commun. 446:1255–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rani SB, Rathod SS, Karthik S, Kaur N,
Muzumdar D and Shiras AS: MiR-145 functions as a tumor-suppressive
RNA by targeting Sox9 and adducin 3 in human glioma cells. Neuro
Oncol. 15:1302–1316. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang H, Pu J, Qi T, Qi M, Yang C, Li S,
Huang K, Zheng L and Tong Q: MicroRNA-145 inhibits the growth,
invasion, metastasis and angiogenesis of neuroblastoma cells
through targeting hypoxia-inducible factor 2 alpha. Oncogene.
33:387–397. 2014. View Article : Google Scholar
|
21
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
22
|
Lee HK, Bier A, Cazacu S, Finniss S, Xiang
C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang
W and Li L: MicroRNA-145 inhibits tumour growth and metastasis in
colorectal cancer by targeting fascin-1. Br J Cancer.
110:2300–2309. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kano M, Seki N, Kikkawa N, Fujimura L,
Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M and
Matsubara H: miR-145, miR-133a and miR-133b: Tumor-suppressive
miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J
Cancer. 127:2804–2814. 2010. View Article : Google Scholar
|
25
|
Speranza MC, Frattini V, Pisati F, Kapetis
D, Porrati P, Eoli M, Pellegatta S and Finocchiaro G: NEDD9, a
novel target of miR-145, increases the invasiveness of
glioblastoma. Oncotarget. 3:723–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yang S, Huang FK, Huang J, Chen S,
Jakoncic J, Leo-Macias A, Diaz-Avalos R, Chen L, Zhang JJ and Huang
XY: Molecular mechanism of fascin function in filopodial formation.
J Biol Chem. 288:274–284. 2013. View Article : Google Scholar :
|
27
|
Machesky LM and Li A: Fascin: Invasive
filopodia promoting metastasis. Commun Integr Biol. 3:263–270.
2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Yamakita Y, Matsumura F, Lipscomb MW, Chou
PC, Werlen G, Burkhardt JK and Yamashiro S: Fascin1 promotes cell
migration of mature dendritic cells. J Immunol. 186:2850–2859.
2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Guo L, Bai H, Zou D, Zou D, Hong T, Liu J,
Huang J, He P, Zhou Q and He J: The role of microRNA-133b and its
target gene FSCN1 in gastric cancer. J Exp Clin Cancer Res.
33:992014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tsai WC, Jin JS, Chang WK, Chan DC, Yeh
MK, Cherng SC, Lin LF, Sheu LF and Chao YC: Association of
cortactin and fascin-1 expression in gastric adenocarcinoma:
Correlation with clinicopathological parameters. J Histochem
Cytochem. 55:955–962. 2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Fu H, Wen JF, Hu ZL, Luo GQ and Ren HZ:
Knockdown of fascin1 expression suppresses the proliferation and
metastasis of gastric cancer cells. Pathology. 41:655–660. 2009.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Fu H, Hu Z, Wen J, Wang K and Liu Y:
TGF-beta promotes invasion and metastasis of gastric cancer cells
by increasing fascin1 expression via ERK and JNK signal pathways.
Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar
|
33
|
Chiyomaru T, Enokida H, Tatarano S,
Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N
and Nakagawa M: miR-145 and miR-133a function as tumour suppressors
and directly regulate FSCN1 expression in bladder cancer. Br J
Cancer. 102:883–891. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Akanuma N, Hoshino I, Akutsu Y, Murakami
K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M,
et al: MicroRNA-133a regulates the mRNAs of two
inva-dopodia-related proteins, FSCN1 and MMP14, in esophageal
cancer. Br J Cancer. 110:189–198. 2014. View Article : Google Scholar :
|
35
|
Chen MB, Wei MX, Han JY, Wu XY, Li C, Wang
J, Shen W and Lu PH: MicroRNA-451 regulates AMPK/mTORC1 signaling
and fascin1 expression in HT-29 colorectal cancer. Cell Signal.
26:102–109. 2014. View Article : Google Scholar
|